The analysis also extended to disease-specific survival (DSS), where reduced USP37 expression corresponded to better DSS outcomes in ACC (HR = 1.97, 95% CI [1.35–2.89], p = 0.00058), LGG (HR = 1.47, 95% CI [1.07–2.02], p = 0.02), and LIHC (HR = 1.22, 95% CI [1.02–1.46], p = 0.03). The gene discussed is USP37; the disease is adrenal cortex carcinoma.